CALL FOR ABSTRACTS

Abstract submission is now open.

Submission Close Date: June 1, 2023

ENCORE POSTERS ARE WELCOME!

We invite all registered meeting attendees to submit abstracts for posters of their latest research on the following topics:

• Thyroid disorders
• Pituitary and adrenal disorders
• Polycystic ovary syndrome (PCOS)
• Osteoporosis
• Diabetes
• Obesity management
• Chronic kidney disease & diabetes
• Nonalcoholic fatty liver disease (NAFLD)

All accepted abstracts will be displayed on our virtual platform for the Metabolic and Endocrine Disease Summit Summer to be held July 13–15, 2023 and in person at the Metabolic and Endocrine Disease Summit Fall, October 12-14, 2023, to be held in Orlando, Florida.

Please note at least one author must be registered for the in-person conference in October to be considered for display.

In addition, approved abstracts will also be submitted and indexed through our partner brand Read by QxMD. The platform drives awareness, dissemination and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops), and uses channels such as mobile, email and push notification to connect with our global community of healthcare providers and researchers.

Download the App:

If you are returning to complete or check the status of your submission, please sign-in using your email address and password.

Fee: No fee for non-industry-sponsored abstracts; $495 per abstract for industry-sponsored abstracts.

Abstract Formatting and Content Guidelines
You must be registered for the meeting to have your abstract considered for a presentation.

• Language: English 
• Authors: full last name, first name, affiliations, degrees and contact information
• Font: Arial
• Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)
• Maximum of 2 relevant tables or figures submitted as attachments (not embedded in the file): must be 600 dpi .jpg 
• References must be included as parenthetical in-text citations - first author, et al, journal and year - (Cruz D, et al. Blood 2012)
• Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email) 
• Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, and Conclusions 
• Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.

Notification Date: June 8, 2023

If you have any questions, please contact Tara Stewart
tstewart@medscapelive.com